U.S. markets closed

Eli Lilly and Company (LLY)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
339.08+8.38 (+2.53%)
Al cierre: 04:02PM EST
338.06 -1.02 (-0.30%)
Fuera de horario: 07:59PM EST

Eli Lilly and Company

Lilly Corporate Center
Indianapolis, IN 46285
United States
317 276 2000
https://www.lilly.com

Sector(es)Healthcare
IndustriaDrug Manufacturers—General
Empleados a tiempo completo35,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. David A. RicksChairman, CEO & Pres4.1MN/D1968
Ms. Anat AshkenaziSr. VP & CFO1.91MN/D1972
Dr. Daniel M. Skovronsky M.D., Ph.D.Sr. VP, Chief Scientific & Medical Officer and Pres of Lilly Research Labs2.16MN/D1974
Mr. Diogo RauSr. VP & Chief Information and Digital Officer1.06MN/DN/D
Mr. Jacob S. Van NaardenSr. VP, CEO of Loxo Oncology & Pres of Lilly Oncology2.01MN/D1985
Mr. Donald A. ZakrowskiChief Accounting Officer & VP of Fin.N/DN/DN/D
Mr. Martin Bott MIBSVP of Fin. & Special ProjectsN/DN/D1963
Ms. Anat Hakim J.D.Sr. VP, Gen. Counsel & Sec.N/DN/D1969
Mr. Alonzo WeemsSr. VP and Chief Ethics & Compliance OfficerN/DN/DN/D
Ms. Leigh Ann PuseySr. VP of Corp. Affairs & CommunicationsN/DN/D1963
Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Gestión corporativa

La calificación ISS Governance QuickScore de Eli Lilly and Company a partir del 1 de febrero de 2023 es 5. Las puntuaciones principales son Auditoría: 3; Junta: 5; Derechos del accionista: 9; Compensación: 2.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.